CDX2 and neoplasm: The present study confirms previous results suggesting a relationship between loss of CDX2 expression and a higher malignancy grade, right-sided tumour, and dMMR.3,4,6,7,11,15,19 This is not surprising and a natural consequence of the relation to the consensus molecular subtype (CMS) group I as recently shown by Pilati et al.11